Why is a two-person check important for high-risk meds, and what should be verified?

Why is a two-person check important for high-risk meds, and what should be verified?

• A. To reduce medication errors; verify patient identity, drug name, dose, route, time, and expiration; ensure proper preparation and administration.
• B. To speed up administration by skipping checks.
• C. To delegate all checks to the patient.
• D. To ensure the patient signs the MAR.

Answer: (A)

Two-person checks on high‑risk medications serve as a safety net, adding an independent verification by a second qualified clinician before the drug is given. This extra set of eyes helps catch errors that can slip through a single check—such as misidentified patient, wrong drug, incorrect dose, or improper preparation—before harm can occur. In practice, verification should confirm the patient’s identity, the exact drug name, the correct dose, the intended route, the correct time or schedule, and that the product is not expired. It also includes ensuring proper preparation and labeling, checking for compatibility or appropriate dilution for IV meds, confirming the infusion rate if needed, and reviewing allergies and the MAR to make sure the order matches. This approach strengthens safety without removing responsibility from any one clinician. It’s not about speeding things up, delegating all checks to the patient, or relying solely on a MAR signature.

Two-person checks on high‑risk medications serve as a safety net, adding an independent verification by a second qualified clinician before the drug is given. This extra set of eyes helps catch errors that can slip through a single check—such as misidentified patient, wrong drug, incorrect dose, or improper preparation—before harm can occur. In practice, verification should confirm the patient’s identity, the exact drug name, the correct dose, the intended route, the correct time or schedule, and that the product is not expired. It also includes ensuring proper preparation and labeling, checking for compatibility or appropriate dilution for IV meds, confirming the infusion rate if needed, and reviewing allergies and the MAR to make sure the order matches. This approach strengthens safety without removing responsibility from any one clinician. It’s not about speeding things up, delegating all checks to the patient, or relying solely on a MAR signature.